BRADYKININ STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN GUINEA-PIG ILEUM LONGITUDINAL MUSCLE

被引:34
|
作者
RANSOM, RW [1 ]
GOODMAN, CB [1 ]
YOUNG, GS [1 ]
机构
[1] FLORIDA A&M UNIV,COLL PHARM,TALLAHASSEE,FL 32307
关键词
BRADYKININ; PHOSPHOINOSITIDE HYDROLYSIS; B2; RECEPTORS;
D O I
10.1111/j.1476-5381.1992.tb09078.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Bradykinin (BK)-induced contraction of ileal smooth muscle is assumed to be due to phosphoinositide hydrolysis but this has never been reported. We have investigated whether BK receptors are linked to this transduction mechanism in guinea-pig ileum longitudinal muscle and determined whether these receptors are equivalent to those labelled in [H-3]-BK binding assays. 2 In membranes prepared from longitudinal muscle, [H-3]-BK bound to a single class of sites with high affinity. Characterization of the binding with BK analogues indicated that the radioligand selectivity labelled a B2 type receptor. 3 BK significantly elevated tissue levels of [H-3]-inositol phosphates in longitudinal muscle slices preincubated with [H-3]-myo-inositol. The agonists potencies of BK, Lys-BK, Met-Lys-BK, Tyr5-BK and Tyr8-BK were in agreement with their relative potencies in the binding assay. The B1 receptor agonist des-Arg9-BK, did not stimulate inositol phosphate production. The response to BK was blocked by known B2 receptor antagonists but not by the B1 antagonist des-Arg9, Leu8-BK. 4 BK-induced phosphoinositide hydrolysis was unaffected by exposure of muscle slices to either atropine or indomethacin. 5 The results indicate that the B2 receptors linked to phosphoinositide turnover in ileal longitudinal muscle exhibit properties similar to those involved in contractile responses. Also, the receptor mediating the phosphoinositide response is likely to be that labelled in the [H-3]-BK binding studies.
引用
收藏
页码:919 / 924
页数:6
相关论文
共 50 条
  • [1] ANALYSIS OF THE MECHANISMS UNDERLYING THE BIPHASIC RESPONSES TO BRADYKININ IN CIRCULAR MUSCLE FROM GUINEA-PIG ILEUM
    MEDEIROS, YS
    CALIXTO, JB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 241 (2-3) : 157 - 163
  • [2] QSAR IN BRADYKININ ANTAGONISTS - INHIBITION OF THE BRADYKININ-INDUCED CONTRACTION OF THE ISOLATED RAT UTERUS AND GUINEA-PIG ILEUM
    DECASTRO, LFP
    REISSMANN, S
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1995, 14 (03): : 249 - 257
  • [3] Modulation of the release of endogenous adenosine by cannabinoids in the myenteric preparation of the guinea-pig plexus-longitudinal muscle ileum
    Begg, M
    Dale, N
    Llaudet, E
    Molleman, A
    Parsons, ME
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 137 (08) : 1298 - 1304
  • [4] Postnatal downregulation of inhibitory neuromuscular transmission to the longitudinal muscle of the guinea pig ileum
    Bian, X.
    Burda, J. E.
    Carrasquillo, M.
    Galligan, J. J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2009, 21 (09) : 969 - 977
  • [5] EFFECTS OF CALCITONIN-GENE-RELATED PEPTIDE ON CYCLIC-AMP PRODUCTION AND RELAXATION OF LONGITUDINAL MUSCLE OF GUINEA-PIG ILEUM
    SUN, YD
    BENISHIN, CG
    PEPTIDES, 1995, 16 (02) : 293 - 297
  • [6] FLAVONOID ANTAGONISM OF SPASMOGENIC EFFECT OF ANGIOTENSIN BRADYKININ AND ELEDOISIN ON GUINEA PIG ILEUM
    CHAU, TT
    HALEY, TJ
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (05) : 621 - &
  • [7] BRADYKININ INHIBITS ADENYLATE-CYCLASE ACTIVITY IN GUINEA-PIG ILEUM MEMBRANES VIA A SEPARATE HIGH-AFFINITY BRADYKININ B-2 RECEPTOR
    LIEBMANN, C
    MAMMERY, K
    GRANESS, A
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 288 (01): : 35 - 43
  • [8] BRADYKININ-INDUCED CONTRACTION OF GUINEA-PIG LUNG IN-VITRO
    LACH, E
    TRIFILIEFF, A
    MOUSLI, M
    LANDRY, Y
    GIES, JP
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1994, 350 (02) : 201 - 208
  • [9] Interaction of αβ-Methylene ATP with the Cholinergic Twitch Response in the Guinea-Pig Ileum
    Donnerer, Josef
    Liebmann, Ingrid
    PHARMACOLOGY, 2016, 97 (5-6) : 277 - 281
  • [10] Methoctramine and gallamine inhibit PI hydrolysis in guinea-pig gallbladder
    Cabadak, H
    Kan, B
    VASCULAR PHARMACOLOGY, 2005, 43 (04) : 242 - 246